Kliniska studier för Övervikt i Nebraska
10 studier för Övervikt söker deltagare vid platser i Nebraska.
Städer i Nebraska
Officiell studietext (engelska)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- University Of Nebraska Medical Center, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07595549A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Omaha Childrens Hospital, Omaha
- Velocity Clinical Research, Omaha
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06672549A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Omaha
- Research Site, Omaha
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Bryan Heart, Lincoln
- University of Nebraska Medical Center, Omaha
- Primary Clinical Research, Papillion
RekryterarFas 3
Ålder 45 till 99 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07037433Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Bryan Heart, Lincoln
RekryterarFas 3
Ålder 18 till 99 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07037459A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Omaha
RekryterarFas 3Friska volontärer välkomna
Ålder 18 till 79 · Alla kön · Uppdaterad 11 sep. 2026 · NCT07654374Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Lincoln
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07284901A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Bryan Heart, Lincoln
- Velocity Clinical Research Lincoln, Lincoln
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT07567001Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Omaha
RekryterarFas 3
Ålder 18 till 79 · Alla kön · Uppdaterad 10 aug. 2026 · NCT07654361A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research - Omaha, Omaha
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 22 juli 2026 · NCT07477704Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.